---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-089923"
form_type: "8-K"
ticker: "GRDX"
cik: "0001604191"
company_name: "GridAI Technologies Corp."
filed_at: "2024-08-15T23:59:59+00:00"
generated_at: "2026-05-31T09:00:58.331124+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Entero Therapeutics' auditor Forvis Mazars resigns over financial reporting reliability concerns

## Summary
- Forvis Mazars resigned as independent auditor on Aug 9, 2024, citing belief that cost reduction measures prevent reliable financial reporting.
- Company disagrees with auditor's belief and states it has sufficient management and governance.
- Forvis Mazars was appointed on June 1, 2024 and never issued audit reports for fiscal years 2022 and 2023.
- Board appointed Timothy R. Ramdeen as new director; he brings life science investment experience.
- Board filled audit committee vacancies: Chaitan Khosla and Alastair Riddell appointed, Edward Borkowski named Audit Chair and Compensation Committee Chair.

## SEC filing metadata
- accession: 0001104659-24-089923
- form_type: 8-K
- ticker: GRDX
- cik: 0001604191
- company_name: GridAI Technologies Corp.
- filed_at: 2024-08-15T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 4.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604191/000110465924089923/0001104659-24-089923-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604191/000110465924089923/tm2421756d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-089923
- JSON: https://secwatch.observer/filing/0001104659-24-089923.json
- Plain text: https://secwatch.observer/filing/0001104659-24-089923.txt

## Key facts
- Executive change
  Timothy R. Ramdeen was appointed as Director at GridAI Technologies Corp..
  - Action: appointed
  - Role: Director
  source text: appointed Timothy R. Ramdeen as a member of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1604191/000110465924089923/0001104659-24-089923-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.